Pulmonx Corp (LUNG) Q4 2025 Earnings Call Highlights: Strategic Restructuring and Sales Force ... [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Release Date: March 04, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Pulmonx Corp ( NASDAQ:LUNG ) has executed a cost restructuring initiative, reducing ongoing operating expenses by over 10%, which strengthens their financial outlook. The company closed on a $60 million credit facility with a 5-year interest-only structure, extending debt maturity to 2031 and providing additional financial flexibility. Pulmonx Corp ( NASDAQ:LUNG ) has filled the majority of open US sales positions, which is expected to drive sales growth in the latter half of the year. The company is focusing on high-impact mandates and streamlining priorities to enhance sales team efficiency and effectiveness. Enrollment momentum in the Aeroseal program is accelerating, with expectations to complete the trial by 2027, potentially expanding the market by 20% globally. Negative Points
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx (LUNG) had its price target lowered by Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.MarketBeat
- Pulmonx (LUNG) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $14.00 price target on the stock.MarketBeat
- Pulmonx Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Pulmonx (LUNG) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
LUNG
Earnings
- 3/4/26 - Beat
LUNG
Analyst Actions
- 3/5/26 - Canaccord Genuity
LUNG
Sec Filings
- 3/10/26 - Form S-8
- 3/10/26 - Form 10-K
- 3/9/26 - Form SCHEDULE
- LUNG's page on the SEC website